Tumors positive for estrogen receptors are the most common subtype of breast cancer. This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free ...
Mariano Barbacid's team achieved complete tumor eradication in animal models and now seeks funding to advance the therapy ...
Discover the latest advancements in pancreatic cancer treatment, including targeted therapies and next-generation sequencing, transforming patient care and outcomes.
According to CNIO, among the various kinds of cancer, pancreatic cancer remains one of the deadliest and is a widely known tumor at a molecular level, with an immensely low survival rate.
Uppthera Inc. has patented new proteolysis targeting chimera (PROTAC) compounds comprising cereblon E3 ubiquitin ligase-binding moiety covalently linked to Aurora kinase A (AURKA; ARK1)-targeting ...